Iba sa: Transparency notification
20 Décembre 2018 - 5:35PM
Iba sa: Transparency notification
IBA - TRANSPARENCY
NOTIFICATION
Louvain-la-Neuve, Belgium, December 20, 2018,
17.35 - IBA (Ion Beam Applications SA), the world’s
leading provider of proton therapy solutions for the treatment of
cancer, announces that it has to issue a transparency notification,
in accordance with Article 14, al. 1 of the Transparency Law of May
2, 2007 on disclosure of major holdings, further to the
notification received on December 20, 2018.
Reason for the notification |
3% Downwards crossing further to the disposal of voting
rights |
Persons subject to the notification
requirement |
IBA SA, issuer |
Persons that dispose of voting rights |
Capfi Delen Asset Management NV. |
Transaction date |
17/12/2018 |
Threshold that is crossed (in %) |
3% Downwards crossing further to the disposal of voting rights |
Denominator |
30 122 528 |
Voting rights (number) |
793 365 |
Voting rights (%) |
2,63 % |
Chain of control |
I. Capfi Delen Asset Management NV, a company incorporated under
Belgian law is directly controlled by Bank Delen NV, a company
incorporated under Belgian law. II. Bank Delen NV is directly
controlled by Delen Investments Comm. VA, a company incorporated
under Belgian law. III. Delen Investments Comm. VA is directly
controlled by Finaxis NV, a company incorporated under Belgian law.
IV. Finaxis NV is directly controlled by Ackermans & Van Haaren
NV, a company incorporated under Belgian law. V. Ackermans &
Van Haaren NV is directly controlled by Scaldis Invest NV, a
company incorporated under Belgian law. VI. Scaldis Invest NV is
directly controlled by Belfimas NV, a company incorporated under
Belgian law. VII. Belfimas NV wordt rechtstreeks gecontroleerd door
Celfloor SA, a company incorporated under Luxembourg law. VIII.
Celfloor SA is directly controlled by Apodia International Holding
BV, a company incorporated under Dutch law. IX. Apodia
International Holding BV is directly controlled by Palamount NV, a
company incorporated under the law of The Netherlands Antilles. X.
Palamount NV is directly controlled by the foundation stichting
administratiekantoor “Het Torentje”, incorporated under Dutch law.
XI. The foundation Stichting Administratiekantoor “Het Torentje”,
is the ultimate controlling shareholder. |
About IBAIBA (Ion Beam Applications S.A.) is a
global medical technology company focused on bringing integrated
and innovative solutions for the diagnosis and treatment of cancer.
The company is the worldwide technology leader in the field of
proton therapy, considered to be the most advanced form of
radiation therapy available today. IBA’s proton therapy solutions
are flexible and adaptable, allowing customers to choose from
universal full-scale proton therapy centers as well as compact,
single room solutions. In addition, IBA also has a radiation
dosimetry business and develops particle accelerators for the
medical world and industry. Headquartered in Belgium and employing
about 1,500 people worldwide, IBA has installed systems across the
world.
IBA is listed on the pan-European stock exchange NYSE EURONEXT
(IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can
be found at: www.iba-worldwide.com
For further information, please contact:
IBA
Stephanie Bauwin Legal Counsel +32 10 203 924
Stephanie.bauwin@iba-group.com
- 20181220transparencyCapfiDelenAssetManagementNVEN
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024